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include intention tremor, cerebellar ataxia, and Parkinsonism [1] . Recently, great emphasis on the pathogenetic role of toxic aggregates, produced by a RAN translation process on the 5' expanded CGG region, has been given [2, 3] . These aggregates contain a small protein with a polyglycin stretch, (FMRpolyG), and so far, have been isolated and characterized in drosophila, mouse model and post mortem FXTAS patients biopsies, but never in living patients. [4] The early diagnosis of this syndrome, in adult carriers of premutations, remains difficult due to the absence of specific markers and, the complexity of the procedure aimed at producing human cellular models, makes the study of the role of these aggregates in the pathogenesis of FXTAS difficult as well. [5] Here we demonstrate, for the first time, using immunocytochemistry (ICC) and Western Blot procedure (WB), that it is possible to easily assess the presence of aggregates containing FMRpolyG protein, in fibroblasts isolated from a clinical and molecular characterized FXTAS living patient, and discuss some possible practical implications.
MATERIALS AND METHODS

Case report
The patient was a 50-year male with a history of tremor and slowness since age 43. He also complained of occasional syncopal episodes. His past and family histories were unremarkable. Neurological examination revealed broad-based gait, facial hypomimia and mild asymmetric (right greater than left) resting tremor in the distal upper and lower extremities, in association with postural and action tremor in the upper limbs. Tone, strength, and sensation were normal. There were also a slight bradykinesia and increased deep tendon reflexes. General physical examination was normal, without sexual or urinary disturbances, except for orthostatic hypotension with a decrease in systolic and diastolic blood pressure of 34 and 14 mmHg respectively, changing position from supine to standing upright. A generalized cerebral atrophy with severe involvement of the cerebellum and of the middle cerebellar peduncles were present in 3T MRI.
Gene Scan analysis
Amplicons depending on the size of the CGG repeat region, were produced using a 
Immunoprecipitation studies
After precleaning with 60 μ l of a Staphylococcus A membrane, the fibroblast' cytosolic fraction, was isolated and incubated overnight at 4°C with a Rabbit anti human HsP70 antibody. The immunocomplexes were separated by SDS page and Western blot and analyzed by using a Mouse anti human FMRpolyG and a goat antimouse HRP conjugated. In a separate experiment, the same rabbit anti Hsp70 antibody, with a secondary anti rabbit HRP conjugated, was used to assess the amount of free Hsp70 (without immunoprecipitation) in fibroblasts from NFPC and patient.
Statistical Analysis
A Kruskall-Wallis test was used to evaluate significant differences in the number of cell positive for FMRpolyG-HSP70 complex, between NFPC and patient.
RESULTS
The molecular analysis of the FMR1CGG repeats shows in our patient a mosaicism for a 44 and 116 CGG expansions in the premuation range for FRAXA.
( Fig 1A) .
To assess the production of FMRpolyG protein we performed immunocytochemistry experiments both on FXTAS patient's and NFPC fibroblasts. To demonstrate that the HSP70 does not merely colocalize with FMRpolyG, but it is a component of the same intracellular complex involved in a defensive reaction against the aggregates, we performed immunoprecipitation experiment on the cytosolic fibroblasts fraction. Fig 2A shows that the anti HSP70 antibody is able to immunoprecipitate the FMRpolyG protein, confirming that there is a specific physical interaction with FMRpolyG as described in the first step of proteosomal mediated degradation pathway. [6] Western blot only for the HSP70 protein on the same amount of cellular extract is shown in figure 2B . According to the defense response, the HSP70 levels are increased in the FXTAS fibroblasts in comparison to the steady state levels in NFPC.
DISCUSSION
Features of FXTAS overlap many other neurodegenerative disorders, including
Parkinson, Alzheimer diseases and frontotemporal dementia (e.g., progressive cognitive impairment, altered mood and behavior). [7] These observations underscore the need to develop a new and reliable diagnostic tool, to confirm the diagnosis of FXTAS. Todd and colleagues recently demonstrated, on postmortem biopsies and murine models, as a translation of CGG repeats without ATG (RAN) occurs in two out of the three frames, giving rise to short proteins containing either a polyalanine or a polyglycine stretch and that polyglycine protein resulted in the formation of heterogeneous protein inclusions, which were toxic both in neuronal transfected cells and in Drosophila . [3] Based on this observation we asked if would have been possible to assess the presence of such aggregates in vivo, in order to open the way towards a novel diagnostic marker for FXTAS in living patients. Starting from the observation that the FMR1 protein is expressed in a wide range of cells, [8] we demonstrate, the presence of FMRpolyG aggregates in fibroblasts from a living patient carrier of a premutated FMR1 allele associated to clinical signs of FXTAS but not in a normal premutated carrier of CGG expansion. To our knowledge this is the first observation in living patients.
Because the increase in the HsP70 level has been described as marker of cellular defense against the inclusions found in neurons and astrocytes from FXTAS post mortem brain, [9] , we also studied such reaction in the fibroblasts of our patient. Our data demonstrating an increase in the amount of total Hsp70, along with an evident molecular interaction 
